SLC7A11 and cancer: Given the widespread involvement of ferroptosis and immune infiltration in the development of various cancer types, we aimed to investigate whether SLC7A11, the key ferroptosis regulator in our study, also predicts poor prognosis and influences the tumor immune microenvironment in other cancer types.